The Pennant Group (NASDAQ:PNTG) Upgraded at Zacks Research

Zacks Research upgraded shares of The Pennant Group (NASDAQ:PNTG) from a hold rating to a strong-buy rating in a report issued on Thursday,Zacks.com reports.

A number of other analysts have also issued reports on the stock. Jefferies Financial Group initiated coverage on shares of The Pennant Group in a research note on Friday, October 24th. They set a “buy” rating and a $30.00 target price for the company. Stephens reissued an “overweight” rating and issued a $40.00 price objective on shares of The Pennant Group in a research report on Thursday, October 9th. Weiss Ratings restated a “hold (c)” rating on shares of The Pennant Group in a research note on Monday, November 17th. Wall Street Zen lowered shares of The Pennant Group from a “buy” rating to a “hold” rating in a research report on Sunday, November 16th. Finally, Royal Bank Of Canada lifted their price target on shares of The Pennant Group from $34.00 to $39.00 and gave the company an “outperform” rating in a research note on Monday, November 17th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $33.60.

The Pennant Group Trading Up 2.9%

NASDAQ:PNTG opened at $26.67 on Thursday. The firm has a market capitalization of $922.52 million, a P/E ratio of 35.56, a PEG ratio of 2.16 and a beta of 1.39. The company’s 50-day simple moving average is $24.95 and its 200 day simple moving average is $25.79. The Pennant Group has a one year low of $21.18 and a one year high of $32.00. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04.

The Pennant Group (NASDAQ:PNTG) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.01. The Pennant Group had a return on equity of 9.37% and a net margin of 3.15%.The firm had revenue of $229.04 million during the quarter, compared to analyst estimates of $221.96 million. The Pennant Group has set its FY 2025 guidance at 1.140-1.180 EPS. As a group, analysts forecast that The Pennant Group will post 0.75 EPS for the current fiscal year.

Hedge Funds Weigh In On The Pennant Group

Large investors have recently bought and sold shares of the business. Quarry LP bought a new stake in The Pennant Group during the 3rd quarter valued at $37,000. State of Alaska Department of Revenue purchased a new stake in shares of The Pennant Group during the 3rd quarter worth $54,000. Tower Research Capital LLC TRC lifted its stake in shares of The Pennant Group by 161.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 3,987 shares of the company’s stock worth $119,000 after purchasing an additional 2,463 shares during the last quarter. AlphaQuest LLC bought a new stake in The Pennant Group during the third quarter valued at about $137,000. Finally, State of Wyoming grew its stake in The Pennant Group by 41.3% in the first quarter. State of Wyoming now owns 6,170 shares of the company’s stock valued at $155,000 after purchasing an additional 1,803 shares during the last quarter. Institutional investors own 85.88% of the company’s stock.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.